Abortion access is about to be back up for debate. A Texas judge in April ruled mifepristone, the most commonly used abortion medication in America, was not approved correctly by th...
Abortion access is about to be back up for debate. A Texas judge in April ruled mifepristone, the most commonly used abortion medication in America, was not approved correctly by the Food and Drug Administration more than two decades ago, and that it should be banned nationwide.
Justices Clarence Thomas and Samuel Alito were the only two to dissent, with Alito writing the drug makers"are not entitled to a stay because they have not shown that they are likely to suffer irreparable harm in the interim." Medication advocate Kirsten Moore says the FDA is no stranger to these kinds of lawsuits, but up until this case, judges have deferred to the FDA's scientific expertise.
"That is going to have a chilling effect on our ability as drug makers, as drug sponsors, to continue to innovate, because it just throws everything up into the air," Moore explained.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
3 judges who chipped away abortion rights to hear federal abortion pill appealThree appeals court judges with a history of supporting restrictions on abortion will hear arguments May 17 on whether a widely used abortion drug should remain available
Baca lebih lajut »
3 Judges Who Chipped Away Abortion Rights To Hear Federal Abortion Pill AppealThree appeals court judges with a history of supporting restrictions on abortion will hear arguments on whether a widely used abortion drug should remain available.
Baca lebih lajut »
3 judges who chipped away abortion rights to hear federal abortion pill appealThe case involves a regulatory issue — whether the Food and Drug Administration’s approval of mifepristone, and subsequent actions making it easier to obtain, must be rolled back.
Baca lebih lajut »
3 appeals court judges who chipped away abortion rights to hear federal mifepristone appealThe case involves a regulatory issue — whether the FDA's approval of abortion pill mifepristone, and subsequent actions making it easier to obtain, must be rolled back.
Baca lebih lajut »
FDA Moves to Curb Misuse of ADHD MedsThe FDA has unveiled fresh measures aimed at tackling persistent worries surrounding the improper use, abuse, addiction, and overdose of prescription stimulants prescribed for ADHD treatment. TwitteRx
Baca lebih lajut »
FDA Clears Renuvion APR Handpiece for Use After LiposuctionThe agency’s update on Wednesday follows three updates on the Renuvion/J-Plasma system in 2022.
Baca lebih lajut »